Home | Services & Solutions | Oligonucleotide

WuXi TIDES oligonucleotide platform provides comprehensive CRDMO services from drug discovery to commercial manufacturing for both drug substance and drug product.

Our oligonucleotide discovery synthesis services support high throughput library synthesis and custom synthesis (nmol-mmol). We cover all types of oligonucleotides, their monomers, linkers, ligands and conjugates. Additionally, we provide dedicated analytical support for all required testing.

We can seamlessly scale up to any scale (mmol – mol) to meet various demands from preclinical, clinical to commercial stages with ample capacities and proven capabilities with commercial success. Beyond chemistry, we provide formulation development and manufacturing services with various dosage forms and filling formats. These services are coupled with comprehensive analytical support for both API and drug product under one quality system, as well as the integrated CMC dossier preparation services, enabling our customers to bring their oligonucleotide therapeutics to market faster.

Oligonucleotide CRDMO Chemistry Platform

from Discovery to Development and Commercial Manufacturing

Monomer / Ligand

Oligonucleotide (from nmol to mol)

Conjugate

Services and Solutions

Why WuXi TIDES?

WuXi TIdes Oligonucleotide
image 113 Oligonucleotide
image 118 Oligonucleotide
image 116 Oligonucleotide
Global Quality Standard
image 115 Oligonucleotide
image 114 Oligonucleotide
Dont edit
Scalability
From discovery to development and commercialization all within WuXi TIDES with readily available large R&D and manufacturing capacity.
Conjugation Chemistry

Seamless collaboration among oligonucleotide, peptide and small molecule teams

New Technology

Biocatalysis for gRNA Synthesis, Thin Film Evaporation (TFE)

Global Quality Standard

One quality system across all sites approved by major regulatory agencies around the world 

Comprehensive Analytical Platform

Method development and validation, IPC and release testing, characterization, stability 

Integrated CMC

API Process Development and Manufacturing, Formulation Development and Manufacturing, Analytical, CMC Dossier Preparation and Clinical Supply Services

Meeting global quality standard

US Oligonucleotide

14

US FDA Inspections

2013-2023

EURO Oligonucleotide

6

EU EMA Inspections

2019-2023

CHINA Oligonucleotide

50

China NMPA Inspections

2015-2024

JAPAN Oligonucleotide

9

Japan PMDA Inspections

2019-2024

SOUTH KOREA Oligonucleotide

4

South Korea MFDS Inspections

2022
SWITZERLAND Oligonucleotide

4

SwissMedic Inspections

2018-2023

How can we help?

Our TIDES Drug Experts Stand Ready.

Small Molecule Projects?

Scroll to Top
Please enable JavaScript in your browser to complete this form.
Checkboxes